BOW
Next earnings: Aug 4, 2026 · Before open
Signal
Mixed11
Price
1
Move+5.10%Strong session
Volume
1
Volume0.0× avgLight volume
Technical
1
RSIRSI 41Momentum negative
PRICE
Prev Close
24.72
Open
25.20
Day Range25.20 – 26.15
25.20
26.15
52W Range21.21 – 40.99
21.21
40.99
24% of range
VOLUME & SIZE
Avg Volume
208.9K
FUNDAMENTALS
P/E Ratio
14.1x
Value territory
EPS (TTM)
Div Yield
No dividend
Performance
1D
+3.59%
5D
+4.63%
1M
+15.45%
3M
+14.19%
6M
+2.13%
YTD
-1.02%
1Y
-26.45%
Best: 1M (+15.45%)Worst: 1Y (-26.45%)
Quick Read
TrendInsufficient MA data
Momentum
BULLISH
revenue +28% YoY
Valuation
FAIR
P/E 14x vs ~20x sector
Health
STRONG
CR 267.5 · FCF $10.42/sh
Bullish
Key MetricsTTM
Market Cap$927.67M
Revenue TTM$583.59M
Net Income TTM$58.37M
Free Cash Flow$341.86M
Gross Margin34.4%
Net Margin10.0%
Operating Margin12.6%
Return on Equity13.4%
Return on Assets2.4%
Debt / Equity0.00
Current Ratio267.48
EPS TTM$1.78
Alpha SignalsFull Analysis →
What Moves This Stock

Combined ratio trends - underwriting profitability measured as (losses + expenses) / premiums, target typically 90-95% for specialty lines

Gross written premium growth rates - indicates market share gains and pricing power in hard market environment

Reserve development - favorable or adverse prior-year loss reserve adjustments signal underwriting accuracy

Rate increases achieved on renewals - pricing power indicator, specialty lines often achieve 10-20%+ in hard markets

Macro Sensitivity
Economic Cycle

moderate - Specialty P&C insurance demand correlates with commercial activity and business formation, but hard market pricing dynamics can offset economic softness. Economic expansion drives increased insurable exposures (payrolls, revenues, property values) which grow premium bases. However, specialty lines often see counter-cyclical opportunities as standard carriers tighten underwriting during downturns, creating E&S market opportunities.

Interest Rates

Rising interest rates are moderately positive for BOW. Higher rates increase investment income on insurance float (reserves held before claims paid), directly improving profitability. The company's zero-debt structure eliminates financing cost concerns. However, rising rates can pressure valuation multiples as investors demand higher equity returns, and may reduce commercial activity that drives insurance demand. The 10-year Treasury yield directly impacts portfolio returns on the estimated $200-300M+ investment portfolio.

Key Risks

Insurance cycle turning - specialty P&C operates in hard/soft cycles; current hard market with strong pricing could soften as capital floods in, compressing margins and growth rates by 2027-2028

Regulatory and legal environment shifts - adverse court rulings expanding liability definitions or state regulatory actions limiting rate increases could pressure underwriting margins

Climate change increasing loss frequency/severity - rising catastrophe losses could exceed pricing assumptions, particularly for property-exposed specialty lines

Investor Profile

growth - The 50%+ revenue growth, 66% EPS growth, and 36% FCF yield attract growth investors seeking high-growth specialty insurers in hard market conditions. However, the 24% one-year decline and compressed 1.5x P/S valuation suggest value investors may also be accumulating on pullback. The zero-debt, cash-generative profile appeals to quality-focused investors. Specialty insurance growth stories typically attract hedge funds and long-only growth managers willing to accept underwriting volatility for outsized returns.

Watch on Earnings
10-Year Treasury yield (GS10) - drives investment income on insurance floatHigh-yield credit spreads (BAMLH0A0HYM2) - signals credit stress impacting investment portfolio and commercial insurance demandCombined ratio reported quarterly - core underwriting profitability, watch for sustained sub-95% performanceGross written premium growth vs. industry benchmarks - market share trajectory in specialty segments
Health Radar
3 strong2 watch1 concern
65/100
Liquidity
267.48Strong
Leverage
0.00Strong
Coverage
41.6xStrong
ROE
13.4%Watch
ROIC
3.4%Concern
Cash
$234MWatch
ANALYST COVERAGE7 analysts
BUY
+23.2%upside to target
L $27.00
Med $32.00consensus
H $33.00
Buy
571%
Hold
229%
5 Buy (71%)2 Hold (29%)0 Sell (0%)
Full report →
Stock Health
Composite Score
4 of 5 signals bullish
8/10
Technicals
RSI RangeRSI 41 — Bearish momentum
Volume
Volume FlowAccumulation — institutional buying
Fundamentals
Last EarningsBeat estimates
Analyst ConsensusBuy
LiquidityCurrent Ratio 267.48 — healthy liquidity
Upcoming Events
EEarnings ReportMay 18, 2026
Tomorrow
DEx-Dividend DateAug 14, 2026
In 89 days
PDividend PaymentAug 28, 2026
In 103 days
Technicals
Technical SetupBEARISH
Technicals →

Trend

RallyDeath Cross · 50D trails 200D by 15.1%

+2.0% vs SMA 50 · -13.3% vs SMA 200

Momentum

RSI41.0
Momentum fading
MACD-0.17
Below zero — bearish pulse · compressing
Market Position
Price Levels
52W High
$40.98+57.8%
EMA 200
$30.16+16.1%
Current
$25.98
EMA 50
$25.37-2.3%
52W Low
$21.21-18.4%
52-Week RangeNear 52-week low
$21.2124th %ile$40.98
Squeeze SetupVolume-based
Elevated Squeeze Setup

Strong accumulation on above-average volume. Buyers are absorbing supply aggressively — any positive catalyst could trigger a rapid covering move.

20-Day Money Flow
Acc days:8
Dist days:2
Edge:+6 acc
Volume Context
Avg Vol (50D)209K
Recent Vol (5D)
272K+30%

Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.

Earnings & Analysts

ANALYST ESTIMATES

Consensus of 5 analysts
Analyst revisions:EPS↓ Revised DownRevenue↓ Revised Down

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2024
$688.1M
$681.0M$695.2M
$1.32
±1%
Moderate3
FY2025
$855.4M
$847.7M$861.2M
+24.3%$1.63+22.9%
±1%
High5
FY2026(current)
$951.1M
$939.2M$959.3M
+11.2%$1.97+21.3%
±1%
Moderate4
Range confidence:Tight (high)ModerateWide (low)
🔥Beat 8 consecutive quarters
Earnings HistoryBOW
Last 8Q
+8.6%avg beat
Beat 8 of 8 quarters Estimates rising
+4%
Q3'24
+3%
Q4'24
+20%
Q1'25
+3%
Q2'25
+3%
Q3'25
+17%
Q4'25
+4%
Q1'26
+14%
Q2'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
Insider Activity
SEC Filings →
1 Buy/5 SellsNet Selling
Botein MatthewDir
$61.3M
Aug 8
SELL
Gallatin Point Capi…Dir
$61.3M
Aug 8
SELL
Schnidman AvaDir
$50K
Feb 28
BUY
Botein MatthewDir
$88.0M
Oct 25
SELL
Gallatin Point Capi…Dir
$88.0M
Oct 25
SELL
American Family Mut…Dir
$37.7M
Oct 25
SELL
Financials

INSTITUTIONAL OWNERSHIP

1
Gallatin Point Capital LLC
9.0M
2
American Family Investments, Inc.
4.7M
3
AMERICAN CENTURY COMPANIES INC
2.0M
4
VICTORY CAPITAL MANAGEMENT INC
1.5M
5
Polar Capital Holdings Plc
1.5M
6
BlackRock, Inc.
1.4M
7
TWO SIGMA INVESTMENTS, LP
519K
8
Gillson Capital LP
436K
News & Activity

BOW News

About

No description available.

PeersFinancial Services(7 companies)
Screen sector →
SymbolPriceDay %Mkt CapP/ERev GrwMarginELO
BOW
$25.98+3.59%$734M15.9+2959.3%975.2%1500
$297.81-0.70%$798.0B14.11501
$325.75+1.00%$624.4B28.0+1134.0%5014.5%1501
$494.20+0.87%$436.7B28.3+1641.6%4564.7%1492
$49.77+0.00%$353.2B-45.1%1496
$192.51-1.04%$303.6B16.6+1147.7%1466.4%1528
$948.47-2.11%$279.8B15.9-138.4%1373.0%1524
Sector avg+0.23%19.8+1116.5%2678.8%1506